Login / Signup

The prospective record-breaking obesity drug tirzepatide raises concerns about affordability.

Rajmohan V SeetharamanSwarnima PanditShirish Shashikant Joshi
Published in: Journal of basic and clinical physiology and pharmacology (2023)
Keyphrases
  • insulin resistance
  • metabolic syndrome
  • weight loss
  • high fat diet induced
  • type diabetes
  • weight gain
  • adverse drug
  • body mass index
  • adipose tissue
  • physical activity